Thy1.1 transgenic mice: In vivo congenic tracking and selective cell-depletion model via Thy1.1 allelic marking
Gene Information: The B-Thy1.1 mouse model carries the Thy1.1 allelic variant (encoding Thy1.1, typically derived from AKR mice) on an otherwise standard (such as C57BL/6, which natively expresses Thy1.2) genetic background.
Protein Expression: The encoded Thy1.1 antigen is a glycosylphosphatidylinositol(GPI)-anchored cell-surface glycoprotein selectively expressed on thymocytes, mature peripheral T lymphocytes, hematopoietic stem cells, and neurons.
Signaling Pathway: Localized within lipid rafts, Thy-1 couples with Src-family kinases and integrin co-receptors to transduce downstream signals regulating T-cell costimulation, cytoskeletal rearrangement, cell adhesion, and survival.
Therapeutic Inhibition: Monoclonal antibodies targeting Thy1.1 enable selective in vivo depletion or tracking of Thy1.1 donor T cells and evaluation of immunotherapies without cross-reacting with host Thy1.2 immune cell populations.
Thy1.1 expression analysis in homozygous Thy1.1 transgenic mice by flow cytometry. Splenocytes, blood and thymocytes were collected from wild-type C57BL/6 mice (+/+) and homozygous B-Thy1.1 mice (Mut/Mut), and then analyzed by flow cytometry with anti-Thy1.1 and anti-Thy1.2 antibodies.